|
|
|
|
|
|
|
|
|
|
|
|
|
24.04.25 - 22:06
|
Varex Schedules Second Quarter Fiscal Year 2025 Earnings Release and Conference Call (Business Wire)
|
|
|
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2025, following the close of regular trading on Thursday, May 8, 2025. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day.
This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from May 8th through May 22nd at 877-660-6853 from anywhere in the U.S. or 201-612-7415 from non-U.S. locations. The replay conference call access code is 13753373. The listen-only webcast link is: https://event.choruscall.com/mediaframe/webcast.html?webcastid=lX6SZW6F.
About Varex
Varex Imaging Corporation is...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
06.02.25 - 22:09
|
Varex Announces Financial Results for First Quarter Fiscal Year 2025 (Business Wire)
|
|
|
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the first quarter of fiscal year 2025.
1QFY25 Summary
Revenues of $200 million
GAAP gross margin 34% | Non-GAAP gross margin* 35%
GAAP operating margin 6% | Non-GAAP operating margin* 7%
GAAP net loss $0.01 per diluted share | Non-GAAP net earnings* $0.07 per diluted share
Cash flow from operations was $10 million
Sunny Sanyal, Chief Executive Officer, stated, "Demand in the first quarter was solid, with both Medical and Industrial revenue up year-over-year. Favorable sales mix and productivity gains across both segments resulted in higher than expected profitability and earnings per share." Sanyal added, "We expect to see continued solid demand across both segments in the second quarter of fiscal 2025."
Varex's revenue of $200 million was up 5% year-over-year. Medical segment revenue of $145 million was up 3% year-over-year. Industrial segment revenue of $55 m...
|
|
|
22.01.25 - 22:09
|
Varex Schedules First Quarter Fiscal Year 2025 Earnings Release and Conference Call (Business Wire)
|
|
|
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the first quarter of fiscal year 2025 following the close of regular trading on Thursday, February 6, 2025. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day.
This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also access this conference call at 877-524-8416 from anywhere in the U.S. or 412-902-1028 from non-U.S. locations. The webcast of this call will be archived on the company's website and a replay of the call will be available from February 6th through February 20th at 877-660-6853 from anywhere in the U.S. or 201-612-7415 from non-U.S. locations. The replay conference call access code is 13751211. The listen-only webcast link is: https://event.choruscall.com/mediaframe/webcast.html?webcastid=8hRSur2G
About Varex
Varex Imaging Co...
|
|
|
23.12.24 - 15:57
|
Varex Announces Closing of Private Offering of $125 Million of Senior Secured Notes (Business Wire)
|
|
|
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced it has closed its private offering (the “Offering”) of $125 million aggregate principal amount of 7.875% senior secured notes due 2027 (the “notes”) at an offering price of 101.5% of the principal amount thereof, plus accrued interest from and including October 15, 2024.
“We are pleased to have successfully closed the offering of additional senior secured notes,” said Sam Maheshwari, Chief Financial Officer of Varex Imaging Corporation. “The additional funds allow us to address the partial repayment of our convertible notes coming due in June 2025, while preserving availability under our revolving credit facility,” added Maheshwari.
Additional information concerning the notes is disclosed in Varex's Form 8-K filed today, December 23, 2024.
No Offer or Solicitation
Nothing contained herein shall constitute an offer to sell or the solicitation of an offer to buy any security. The notes were offered and...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
